Latest Articles

This article will cover the theory underpinning multivariate analysis of variance (MANOVA), which expands on the capabilities of ANOVA, the types of MANOVA and a worked example of the test.

Flow cytometry (FC) is a powerful tool for multi-parametric cell characterization. In this article, we explore the advances improving the accuracy and efficiency of FC and opening up new research and clinical applications.

In this article, LGBTQIA+ scientists share what they enjoy most about their work, discuss the primary hurdles LGBTQIA+ individuals encounter in STEMM and offer advice to young professionals entering the field.

Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse stem cell lines for disease research could improve global health equity.

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of these models, ultimately increasing drug testing accuracy and revolutionizing biomedical science.

Allyship in STEMM requires active listening, unlearning biases and advocating for equity. This article explores how inclusion drives innovation and how small actions can create meaningful change in building a more diverse, inclusive community.

C-Path, a nonprofit organization created to improve drug development, has been working to facilitate the adoption of MPS as drug development tools in regulatory science. In this interview, we learn how.

Prokaryotes are unicellular organisms that lack membrane-bound structures. This article details the structure of prokaryotic cells and provides examples of prokaryotic organisms.

Researchers have developed a new electrically active biomaterial that can be transplanted into the body to improve recovery following central nervous system injuries. The material acts as a scaffold that also provides electrical stimulation.

Technology Networks spoke with Dr. Thomas Dennison, University of Cambridge, to learn more about the advantages of using patient-derived organoids for modeling inflammatory bowel disease (IBD).